Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| Line 62: | Line 62: | ||
: QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles | : QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles | ||
| + | |||
==Statements of Endorsement== | ==Statements of Endorsement== | ||
| Line 67: | Line 68: | ||
*[[Clinical Sites]] | *[[Clinical Sites]] | ||
*[[Additional letters of support can be found here]] | *[[Additional letters of support can be found here]] | ||
| − | |||
==See Also== | ==See Also== | ||
Revision as of 17:29, 14 January 2020
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Profiles may be of use at any Stage.
Stage 3: Technically Confirmed Profiles
- Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
- Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
Please submit comments using the online form
- SPECT-CT: Estimating the Concentration of 99mTc Based Imaging Biomarkers in Large and Small Volumes of Interest Profile 2019-10-21 (Public Comment Open: November 1, 2019 - February 3, 2020)
- QIBA US Measurement of Shear Wave Speed for Estimation of Liver Fibrosis Profile 2019-10-21 (closed on December 18, 2019)
- Appendix E: QIBA US SWS Checklists for Implementation of the SWS Profile, 2019-10-21 (closed on December 18, 2019)
- QIBA CT Lung Density Profile 2019-09-03 (Contains Conformance Checklist, Appendix B) (closed on October 16, 2019)
- QIBA CT Lung Density Protocols-Appendix D, 2019-06-26 (closed on October 16, 2019)
- Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05 (closed on April 5th, 2019)
- Atherosclerosis Biomarkers by (C)CTA - 2019 Imaging Profile 2019-02-26 (closed on June 3rd, 2019)
Comment Resolutions are posted for Past Public Comments and Past Technical Confirmations.
Format for Citing Profiles
Cite QIBA Profile documents as:
- Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. QIBA, Date. Available from: URL
Example:
- QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)